PROGEN

PROGEN is a 100% subsidiary of the R-Biopharm AG.

PROGEN’s products can be divided into six categories:

• Antibodies: premium research antibodies. PROGEN’s antibodies are published in biomedical and cell biology literature.
• AAV: Unique range of adeno-associated virus (AAV) antibodies and quantification ELISAs for gene therapy research.
• Antigens and Controls: various purified and recombinant proteins to support your research.
• Density Gradient Media: density gradient media for the isolation of cells, subcellular membranes, viruses and macromolecules using centrifugation techniques.
• Diagnostic Assays: in vitro diagnostic (IVD) and research (RUO) test based on ELISA technology and IFT/IFA.
• Phage Display: Antibody hyperphage display technology for the generation of recombinant antibodies, proteins or peptides – a leap forward in functional gene analysis.

“Passion for research,,

The focus of PROGEN on research and development has resulted in the “ Innovative through Research” award of the German Stifterverband in 2018. Progen, specialist for premium immunochemicals since 1983, develops and manufactures test kits and reagents. The product portfolio is expanded on a continuous basis.

PROGEN commits to quality. The company’s quality management system has been certified to EN ISO 13485:2003 + AC:2007 standard. The PROGEN products meet the essential requirements of the directive 98/79/EC of 27 October 1998 on in vitro diagnostic medical devices. Antibodies are manufactured in Germany and PROGEN is an expert in documentation. Data on applications, selectivity and positive controls is available for many products.

For more information about PROGEN and their portfolio please contact us.